Optimal dosing of desvenlafaxine, new insights in gambling and anorexia, and caffeine-induced psychosis.
Hollander
Eric
E
D000241:Adenosine / Q000037:antagonists & inhibitors; D000855:Anorexia / Q000523:psychology*; D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage* / Q000627:therapeutic use*; D002110:Caffeine / Q000009:adverse effects*; D000697:Central Nervous System Stimulants / Q000009:adverse effects*; D003511:Cyclohexanols / Q000008:administration & dosage* / Q000627:therapeutic use*; D005006:Ethnicity; D005715:Gambling / Q000523:psychology*; D006801:Humans; D011605:Psychoses, Substance-Induced / Q000523:psychology*; D000069470:Venlafaxine Hydrochloride
D018687:Antidepressive Agents, Second-Generation; D000697:Central Nervous System Stimulants; D003511:Cyclohexanols; D002110:Caffeine; D000069470:Venlafaxine Hydrochloride; D000241:Adenosine